Quadrant Capital »

Bicara Therapeutics shares owned by Quadrant Capital

Quarter-by-quarter ownership of Bicara Therapeutics (BCAX) shares owned by Quadrant Capital from 13F filings

Historical chart of Quadrant Capital investment in Bicara Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Bicara Therapeutics held by Quadrant Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bicara Therapeutics by Quadrant Capital

Quarter filed Position value Share count Share price at filing
2026-03-31 $259 13 19.92

More positions owned by Quadrant Capital

Ishares Tr Core S&p500 Etf (IVV)
Apple (AAPL)
NVIDIA Corporation (NVDA)
J P Morgan Exchange Traded F Ultra Shrt Etf (JPST)
Alphabet Cap Stk Cl A (GOOGL)
Microsoft Corporation (MSFT)
Ishares Tr Core Msci Eafe (IEFA)
Schwab Strategic Tr Fundamental Us L (FNDX)
Amazon (AMZN)
Ishares Tr Core S&p Mcp Etf (IJH)
Broadcom (AVGO)
Meta Platforms Cl A (META)
Taiwan Semiconductor Manufac Sponsored Ads (TSM)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Procter & Gamble Company (PG)

View all positions for Quadrant Capital

Top funds holding Bicara Therapeutics

RA Capital Management
Vestal Point Capital
Siren
Deep Track Capital
FMR
Henderson Group
T. Rowe Price Investment Management
Red Tree Management
Tpg Gp A
BlackRock
Omega Fund Management
Vanguard Group
Vanguard Capital Management
Citadel Advisors
State Street Corporation

View all funds holding Bicara Therapeutics